AGÕæÈ˹ٷ½

STOCK TITAN

[144] Bicycle Therapeutics plc American SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

MGIC Investment Corp. (MTG) � Form 4 insider transaction

President & COO Salvatore A. Miosi disclosed the sale of 30,000 shares of common stock on 01-Jul-2025 at a weighted-average price of $28.152 per share, generating roughly $0.84 million in proceeds. The disposition was executed under a Rule 10b5-1 trading plan adopted on 06-Mar-2025, indicating the sale was pre-scheduled and not necessarily driven by near-term information.

After the transaction, Miosi directly owns 279,401.361 shares and indirectly controls 384,844 shares via a family trust, maintaining a sizable equity stake. No derivative security activity was reported, and the filing contains no references to earnings, major corporate events, or strategic changes.

The filing primarily records a routine adjustment to the executive’s equity exposure; in isolation, it is unlikely to materially affect the company’s fundamental outlook.

MGIC Investment Corp. (MTG) � Transazione interna Form 4

Il Presidente e COO Salvatore A. Miosi ha comunicato la vendita di 30.000 azioni ordinarie il 01-lug-2025 a un prezzo medio ponderato di 28,152$ per azione, generando circa 0,84 milioni di dollari di proventi. La vendita è stata effettuata nell'ambito di un piano di trading Rule 10b5-1 adottato il 06-mar-2025, segnalando che la cessione era programmata in anticipo e non necessariamente motivata da informazioni a breve termine.

Dopo la transazione, Miosi possiede direttamente 279.401,361 azioni e controlla indirettamente 384.844 azioni tramite un trust familiare, mantenendo una quota azionaria significativa. Non sono state segnalate attività su strumenti derivati e il documento non fa riferimento a utili, eventi aziendali rilevanti o cambiamenti strategici.

Il documento registra principalmente una normale modifica nell’esposizione azionaria dell’esecutivo; isolatamente, è improbabile che influenzi sostanzialmente le prospettive fondamentali della società.

MGIC Investment Corp. (MTG) � Transacción interna Formulario 4

El Presidente y COO Salvatore A. Miosi reveló la venta de 30.000 acciones ordinarias el 01-jul-2025 a un precio promedio ponderado de 28,152$ por acción, generando aproximadamente 0,84 millones de dólares en ingresos. La disposición se realizó bajo un plan de negociación Rule 10b5-1 adoptado el 06-mar-2025, lo que indica que la venta fue programada previamente y no necesariamente impulsada por información a corto plazo.

Tras la transacción, Miosi posee directamente 279.401,361 acciones y controla indirectamente 384.844 acciones a través de un fideicomiso familiar, manteniendo una participación accionaria considerable. No se reportaron actividades con valores derivados y el documento no contiene referencias a ganancias, eventos corporativos importantes ni cambios estratégicos.

El informe principalmente registra un ajuste rutinario en la exposición accionaria del ejecutivo; aisladamente, es poco probable que afecte materialmente las perspectivas fundamentales de la empresa.

MGIC Investment Corp. (MTG) � Form 4 내부� 거래

사장 ê²� COO 살바토레 A. 미오시가 2025ë…� 7ì›� 1ì¼ì— 30,000ì£� 보통ì£�ë¥� 주당 í‰ê·  28.152달러ì—� 매ë„í–ˆìŒì� 공개했으ë©�, ì•� 84ë§� 달러ì� 수ìµì� 창출했습니다. ì� 매ë„ëŠ� 2025ë…� 3ì›� 6ì� 채íƒë� Rule 10b5-1 거래 계íšì—� ë”°ë¼ ì´ë£¨ì–´ì¡Œìœ¼ë©°, ì´ëŠ” ì´ë²ˆ 매ë„ê°€ 사전 예정ë� 것ì´ë©� 단기 ì •ë³´ì—� 따른 ê²ƒì€ ì•„ë‹˜ì� 나타냅니ë‹�.

거래 í›� 미오시는 ì§ì ‘ 279,401.361ì£�ë¥� 보유하고 있으ë©�, ê°€ì¡� ì‹ íƒì� 통해 ê°„ì ‘ì ìœ¼ë¡� 384,844ì£�ë¥� 통제하여 ìƒë‹¹í•� ì§€ë¶„ì„ ìœ ì§€í•˜ê³  있습니다. 파ìƒìƒí’ˆ ê´€ë � 활ë™ì€ ë³´ê³ ë˜ì§€ 않았으며, 제출서류ì—는 수ìµ, 주요 기업 ì´ë²¤íŠ� ë˜ëŠ” ì „ëžµì � ë³€í™”ì— ëŒ€í•� 언급ì� 없습니다.

ì� 제출서류ëŠ� 주로 ê²½ì˜ì§„ì˜ ì§€ë¶� 노출ì—� 대í•� ì¼ìƒì ì¸ ì¡°ì •ì� 기ë¡í•� 것으ë¡�, 단ë…으로 회사ì� 근본ì ì¸ ì „ë§ì—� 중대í•� ì˜í–¥ì� 미칠 ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.

MGIC Investment Corp. (MTG) � Transaction d’initié Formulaire 4

Le Président et COO Salvatore A. Miosi a déclaré la vente de 30 000 actions ordinaires le 01-juil-2025 à un prix moyen pondéré de 28,152$ par action, générant environ 0,84 million de dollars de recettes. La cession a été réalisée dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 06-mars-2025, indiquant que la vente était programmée à l’avance et pas nécessairement motivée par des informations à court terme.

Après la transaction, Miosi détient directement 279 401,361 actions et contrôle indirectement 384 844 actions via une fiducie familiale, conservant une participation importante. Aucune activité sur des titres dérivés n’a été signalée et le dépôt ne fait référence ni aux bénéfices, ni à des événements majeurs de l’entreprise, ni à des changements stratégiques.

Le dépôt enregistre principalement un ajustement de routine de l’exposition aux actions de l’exécutif ; isolément, il est peu probable qu’il ait un impact significatif sur les perspectives fondamentales de la société.

MGIC Investment Corp. (MTG) � Insider-Transaktion Form 4

Präsident und COO Salvatore A. Miosi meldete den Verkauf von 30.000 Stammaktien am 01. Juli 2025 zu einem gewichteten Durchschnittspreis von 28,152$ pro Aktie, was Erlöse von etwa 0,84 Millionen Dollar generierte. Die Veräußerung erfolgte im Rahmen eines Rule 10b5-1 Handelsplans, der am 06. März 2025 angenommen wurde, was darauf hinweist, dass der Verkauf vorab geplant war und nicht unbedingt durch kurzfristige Informationen beeinflusst wurde.

Nach der Transaktion besitzt Miosi direkt 279.401,361 Aktien und kontrolliert indirekt 384.844 Aktien über einen Familientrust, womit er eine bedeutende Beteiligung hält. Es wurden keine Aktivitäten mit Derivaten gemeldet, und die Einreichung enthält keine Hinweise auf Gewinne, wesentliche Unternehmensereignisse oder strategische Änderungen.

Die Meldung dokumentiert hauptsächlich eine routinemäßige Anpassung der Aktienexposition des Geschäftsführers; isoliert betrachtet wird dies die fundamentalen Aussichten des Unternehmens wahrscheinlich nicht wesentlich beeinflussen.

Positive
  • Sale executed under a Rule 10b5-1 plan, reducing concerns about opportunistic insider trading.
  • Executive retains significant ownershipâ€�279,401 direct and 384,844 indirect shares—maintaining alignment with shareholders.
Negative
  • Disposition of 30,000 shares by the President & COO represents a cash realisation of roughly $0.84 million.
  • Direct ownership dilution may be interpreted by some investors as a mildly negative sentiment signal.

Insights

TL;DR Pre-planned 30k-share sale by MTG COO is modest and leaves large stake; overall market impact neutral.

The transaction represents approximately 4â€�5 % of the executive’s combined direct and indirect holdings. Because it was carried out under a Rule 10b5-1 plan, the signalling value is limited. Proceeds of roughly $0.84 million suggest personal diversification rather than a statement on valuation. With no derivative activity or concurrent corporate news, I view the filing as routine and not a catalyst for valuation change.

TL;DR Scheduled sale aligns with governance best practices; minor share reduction poses low governance risk.

Utilising a pre-established 10b5-1 plan mitigates concerns about selective disclosure or opportunistic trading and demonstrates compliance discipline. The officer still holds over 660k shares, maintaining strong alignment with shareholder interests. From a governance perspective, the event is non-problematic and should not influence proxy advisory stances.

MGIC Investment Corp. (MTG) � Transazione interna Form 4

Il Presidente e COO Salvatore A. Miosi ha comunicato la vendita di 30.000 azioni ordinarie il 01-lug-2025 a un prezzo medio ponderato di 28,152$ per azione, generando circa 0,84 milioni di dollari di proventi. La vendita è stata effettuata nell'ambito di un piano di trading Rule 10b5-1 adottato il 06-mar-2025, segnalando che la cessione era programmata in anticipo e non necessariamente motivata da informazioni a breve termine.

Dopo la transazione, Miosi possiede direttamente 279.401,361 azioni e controlla indirettamente 384.844 azioni tramite un trust familiare, mantenendo una quota azionaria significativa. Non sono state segnalate attività su strumenti derivati e il documento non fa riferimento a utili, eventi aziendali rilevanti o cambiamenti strategici.

Il documento registra principalmente una normale modifica nell’esposizione azionaria dell’esecutivo; isolatamente, è improbabile che influenzi sostanzialmente le prospettive fondamentali della società.

MGIC Investment Corp. (MTG) � Transacción interna Formulario 4

El Presidente y COO Salvatore A. Miosi reveló la venta de 30.000 acciones ordinarias el 01-jul-2025 a un precio promedio ponderado de 28,152$ por acción, generando aproximadamente 0,84 millones de dólares en ingresos. La disposición se realizó bajo un plan de negociación Rule 10b5-1 adoptado el 06-mar-2025, lo que indica que la venta fue programada previamente y no necesariamente impulsada por información a corto plazo.

Tras la transacción, Miosi posee directamente 279.401,361 acciones y controla indirectamente 384.844 acciones a través de un fideicomiso familiar, manteniendo una participación accionaria considerable. No se reportaron actividades con valores derivados y el documento no contiene referencias a ganancias, eventos corporativos importantes ni cambios estratégicos.

El informe principalmente registra un ajuste rutinario en la exposición accionaria del ejecutivo; aisladamente, es poco probable que afecte materialmente las perspectivas fundamentales de la empresa.

MGIC Investment Corp. (MTG) � Form 4 내부� 거래

사장 ê²� COO 살바토레 A. 미오시가 2025ë…� 7ì›� 1ì¼ì— 30,000ì£� 보통ì£�ë¥� 주당 í‰ê·  28.152달러ì—� 매ë„í–ˆìŒì� 공개했으ë©�, ì•� 84ë§� 달러ì� 수ìµì� 창출했습니다. ì� 매ë„ëŠ� 2025ë…� 3ì›� 6ì� 채íƒë� Rule 10b5-1 거래 계íšì—� ë”°ë¼ ì´ë£¨ì–´ì¡Œìœ¼ë©°, ì´ëŠ” ì´ë²ˆ 매ë„ê°€ 사전 예정ë� 것ì´ë©� 단기 ì •ë³´ì—� 따른 ê²ƒì€ ì•„ë‹˜ì� 나타냅니ë‹�.

거래 í›� 미오시는 ì§ì ‘ 279,401.361ì£�ë¥� 보유하고 있으ë©�, ê°€ì¡� ì‹ íƒì� 통해 ê°„ì ‘ì ìœ¼ë¡� 384,844ì£�ë¥� 통제하여 ìƒë‹¹í•� ì§€ë¶„ì„ ìœ ì§€í•˜ê³  있습니다. 파ìƒìƒí’ˆ ê´€ë � 활ë™ì€ ë³´ê³ ë˜ì§€ 않았으며, 제출서류ì—는 수ìµ, 주요 기업 ì´ë²¤íŠ� ë˜ëŠ” ì „ëžµì � ë³€í™”ì— ëŒ€í•� 언급ì� 없습니다.

ì� 제출서류ëŠ� 주로 ê²½ì˜ì§„ì˜ ì§€ë¶� 노출ì—� 대í•� ì¼ìƒì ì¸ ì¡°ì •ì� 기ë¡í•� 것으ë¡�, 단ë…으로 회사ì� 근본ì ì¸ ì „ë§ì—� 중대í•� ì˜í–¥ì� 미칠 ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.

MGIC Investment Corp. (MTG) � Transaction d’initié Formulaire 4

Le Président et COO Salvatore A. Miosi a déclaré la vente de 30 000 actions ordinaires le 01-juil-2025 à un prix moyen pondéré de 28,152$ par action, générant environ 0,84 million de dollars de recettes. La cession a été réalisée dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 06-mars-2025, indiquant que la vente était programmée à l’avance et pas nécessairement motivée par des informations à court terme.

Après la transaction, Miosi détient directement 279 401,361 actions et contrôle indirectement 384 844 actions via une fiducie familiale, conservant une participation importante. Aucune activité sur des titres dérivés n’a été signalée et le dépôt ne fait référence ni aux bénéfices, ni à des événements majeurs de l’entreprise, ni à des changements stratégiques.

Le dépôt enregistre principalement un ajustement de routine de l’exposition aux actions de l’exécutif ; isolément, il est peu probable qu’il ait un impact significatif sur les perspectives fondamentales de la société.

MGIC Investment Corp. (MTG) � Insider-Transaktion Form 4

Präsident und COO Salvatore A. Miosi meldete den Verkauf von 30.000 Stammaktien am 01. Juli 2025 zu einem gewichteten Durchschnittspreis von 28,152$ pro Aktie, was Erlöse von etwa 0,84 Millionen Dollar generierte. Die Veräußerung erfolgte im Rahmen eines Rule 10b5-1 Handelsplans, der am 06. März 2025 angenommen wurde, was darauf hinweist, dass der Verkauf vorab geplant war und nicht unbedingt durch kurzfristige Informationen beeinflusst wurde.

Nach der Transaktion besitzt Miosi direkt 279.401,361 Aktien und kontrolliert indirekt 384.844 Aktien über einen Familientrust, womit er eine bedeutende Beteiligung hält. Es wurden keine Aktivitäten mit Derivaten gemeldet, und die Einreichung enthält keine Hinweise auf Gewinne, wesentliche Unternehmensereignisse oder strategische Änderungen.

Die Meldung dokumentiert hauptsächlich eine routinemäßige Anpassung der Aktienexposition des Geschäftsführers; isoliert betrachtet wird dies die fundamentalen Aussichten des Unternehmens wahrscheinlich nicht wesentlich beeinflussen.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many MGIC (MTG) shares did President & COO Salvatore Miosi sell on 1 Jul 2025?

He sold 30,000 shares of MGIC common stock.

At what price were the MTG shares sold according to the Form 4?

The weighted-average sale price was $28.152 per share, with trades ranging from $27.80 to $28.34.

What trading plan covered the MTG insider sale disclosed on July 1, 2025?

The sale was executed under a Rule 10b5-1 trading plan adopted on 06-Mar-2025.

How many MGIC shares does Salvatore Miosi own after the transaction?

He owns 279,401.361 shares directly and 384,844 shares indirectly through a family trust.

Is any derivative security activity reported in this MTG Form 4?

No derivative securities were acquired or disposed of; Table II is blank.

When was the Rule 10b5-1 plan adopted by the MTG executive?

The plan was adopted on 06-Mar-2025.
Bicycle Therapeutics Limited

NASDAQ:BCYC

BCYC Rankings

BCYC Latest News

BCYC Latest SEC Filings

BCYC Stock Data

491.70M
46.97M
1.75%
92.06%
6.1%
Biotechnology
Pharmaceutical Preparations
United Kingdom
CAMBRIDGE